Jazz Pharms., Inc. v. Avadel CNS Pharms., LLC
Announcement from a bar association
Headline as published by Illinois Lawyer Now (ISBA) on Oct 14, 2026; collected by the wire Oct 14, 2026, 12:45 PM ET.
Fed. Cir. Docket Nos. 2024-2274, -2277, -2278 LOURIE, REYNA, TARANTO May 6, 2025 Avadel filed a 505(b)(2) “paper NDA” (AstraZeneca, FC 2010; Takeda, FC 2015) for its Lumryz product, a sodium oxybate formulation for the treatment of excessive daytime sleepiness (“EDS”) and cataplexy in adults with narcolepsy. Jazz asserted infringement of claim 24 of U.S.... Continue Reading
Coverage
Topics
- Bar and practice newsFrom the publisher’s section: no phrase in the text matched, so the tag comes from where Illinois Lawyer Now (ISBA) filed it.
Explore the named firms, organizations and MDL dockets above. Sources and method